1 / 14

Warburg Effect & Oncology

PHM142 Fall 2013 Instructor: Dr. Jeffrey Henderson. Warburg Effect & Oncology. PHM142 October 2, 2013 Alexandra Barany & Noralhuda Emad. What is the Warburg Effect?. Proliferating or Tumor Cells. Differentiated Tissue Cells. - O 2. + O 2. Glucose. Glucose. +/-O 2. Glucose.

dirk
Télécharger la présentation

Warburg Effect & Oncology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PHM142 Fall 2013 Instructor: Dr. Jeffrey Henderson Warburg Effect & Oncology PHM142 October 2, 2013 Alexandra Barany & Noralhuda Emad

  2. What is the Warburg Effect? Proliferating or Tumor Cells Differentiated Tissue Cells -O2 +O2 Glucose Glucose +/-O2 Glucose Pyruvate Pyruvate O2 Lactate 85% Lactate Pyruvate O2 Lactate CO2 (Aerobic Glycolysis) (Oxidative Phosphorylation) (Anaerobic Glycolysis) CO2 Concept adapted from Vander et. al., 2009

  3. What is the Warburg Effect? • Cells metabolize • glucose EVEN • WHEN O2 is • present • They avoid • oxidative • phosphorylation! Pasteur Effect • Glycolysis: glucose  pyruvate (2 ATP) • WITH O2  oxidative phosphorylation • WITHOUT O2 lactate • Reciprocal relationship between • anaerobic glycolysis and oxidative • phosphorylation non existent in the • Warburg effect

  4. Mechanism of Action GLUT MCT Acetyl-CoA for fatty acid synthesis Glucose Glycolysis Pyruvate Lactate 1. 2. Glutamine Acetyl-CoA Citrate TCA Cycle Oxaloacetate Glutamate 2-Oxoglutarate Succinate

  5. Mechanism of Action • Cancerous cells exhibit abnormal behaviours, two of which are: • 1. Production of lactate under aerobic conditions • 2. Inefficient use of glutamine (secrete a significant fraction of glutamine- derived nitrogen and carbon as waste instead of incorporating them into • macromolecule synthesis) • These abnormalities occur because of: • 1. HIF (hypoxia inducible factor) and MYC activate the expression of GLUT and • glycolytic enzymes • 2. HIF diverts pyruvate from the glycolytic TCA cycle • 3. MYC induces glutamine uptake

  6. Reprogramming Cell Metabolism Hsu & Sabatini, 2008

  7. Reprogramming Cell Metabolism Hsu & Sabatini, 2008

  8. Regulation of HIF Fumarate Fe2+ --------| Succinate 2-Oxoglutarate pVHL pVHL --------| PHD HIF-β HIF-β HIF-β OH OH HIF-α HIF-α HIF-α O2 Ub Ub Ub HIF-α destroyed Concept adapted from Kaelin et. al., 2010

  9. Regulation of HIF • HIF-αhydroxylated (addition of –OH) in the presence of oxygen • This is accomplished by the enzyme PHD • PHD itself regulated by oxygen, 2-oxoglutarate, reduced iron, • fumarate and succinate (see previous slide) • pVHL (tumour suppressor protein) recognizes –OH and adds a • ubiquitin chain  degraded by proteasome • In cancer cells, HIF active and leads to abnormal behavior

  10. PI3K/Akt Pathway Thompson & Waird, 2012

  11. Use and Application in Therapy • Used in diagnosis and monitoring of malignant tumors by imaging uptake of a modified radioactive hexokinase substrate using • PET • Develop anti-cancer agents that can inhibit altered metabolic pathways such as glycolysis in cancerous cells (i.e. target enzymes)

  12. Use and Application in Therapy Chen et al, 2007

  13. Summary • Warburg effect describes the preferred metabolic pathway exhibited by cancerous cells oxidative glycolysis • Cells generate ATP through amplified rates of glycolysis and do not go through oxidative phosphorylation as primary pathway of generating ATP, leading to high lactate levels • Warburg’s original observation has been extended to other alterations seen in the metabolism of other molecules (e.g. glutamine) that also characterize cancerous cells differently from normal cells • Cancerous cells exhibit reprogramming of metabolism, where various molecules are metabolized in a way to increase rate of replication and biosynthesis • Altered metabolism triggered by microenvironment and/or signaling pathways • Many altered signaling pathways have been observed to be hallmarks of cancer (e.g.PI3K/Akt pathway and HIF pathway) • Application of Warburg effect is seen in diagnosis of cancer and production of anti-cancer treatments

  14. References • Cantley, L.C.,Thompson, C.B.,& Vander Heiden, M.G. (2009) Understanding the Warburg Effect: The Metabolic Requirements of Cell Metabolism. Science, 324, 1029-1034. • Chen, Z., Garcia-Prieto, C., Huang, P., & Lu,W. (2007) The Warburg Effect and its Cancer Therapeutic Implications. The Journal of Bioenergetics and Biomembranes, 39, 267-274. • Hsu, P.P. & Sabatini, D.M. (2008) Cancer Cell Metabolism: Warburg and Beyond. Cell, 134, 703-708. • Kroemer, G. & Pouyssegur, J. (2008) Tumour cell metabolism: cancer’s Achilles’heel. Cancer Cell, 13, 472-482. • Pathania, D., Millard, M. & Neamati, N. (2009) Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv. Drug Deliv. Rev., 61, 1250-1275. • Thompson, C.B. & Waird,P.S. (2012) Metabolic Reprogramming: A Cancer Hallmark Warburg Did Not Anticipate. Cancer Cell,21, 297-308.

More Related